387 related articles for article (PubMed ID: 23495066)
1. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
[TBL] [Abstract][Full Text] [Related]
2. uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses.
Mian C; Maier K; Comploj E; Lodde M; Berner L; Lusuardi L; Palermo S; Vittadello F; Pycha A
Cancer; 2006 Feb; 108(1):60-5. PubMed ID: 16411183
[TBL] [Abstract][Full Text] [Related]
3. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
[TBL] [Abstract][Full Text] [Related]
4. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
[TBL] [Abstract][Full Text] [Related]
5. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
6. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
Odisho AY; Berry AB; Ahmad AE; Cooperberg MR; Carroll PR; Konety BR
Eur Urol; 2013 May; 63(5):936-40. PubMed ID: 22521093
[TBL] [Abstract][Full Text] [Related]
7. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma.
Têtu B; Tiguert R; Harel F; Fradet Y
Mod Pathol; 2005 Jan; 18(1):83-9. PubMed ID: 15389253
[TBL] [Abstract][Full Text] [Related]
8. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
Jackson J; Barkan GA; Kapur U; Wojcik EM
Cancer Cytopathol; 2013 Jul; 121(7):398-402. PubMed ID: 23364860
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravesical instillation on performance of uCYT+ test.
Lodde M; Mian C; Negri G; Vittadello F; Comploj E; Palermo S; Staffler A; Brössner C; Pycha A
Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970
[TBL] [Abstract][Full Text] [Related]
10. [Value of the uCyt+ test for the detection and followup of bladder tumors].
Drapier E; Renaudin K; Maillet F; Braud G; Laboisse C; Bouchot O
Prog Urol; 2003 Apr; 13(2):222-6. PubMed ID: 12765055
[TBL] [Abstract][Full Text] [Related]
11. ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.
Li HX; Li M; Li CL; Ma JH; Wang MR; Rao J; Pan QJ
Anal Quant Cytol Histol; 2010 Feb; 32(1):45-52. PubMed ID: 20701087
[TBL] [Abstract][Full Text] [Related]
12. [ImmunoCyt--a new urine test in diagnosis of bladder cancer].
Feil G; Bichler KH; Päulgen-Nelde HJ; Hennenlotter J; Zumbrägel A; Stenzl A
Urologe A; 2003 Apr; 42(4):531-7. PubMed ID: 12715125
[TBL] [Abstract][Full Text] [Related]
13. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.
Sullivan PS; Nooraie F; Sanchez H; Hirschowitz S; Levin M; Rao PN; Rao J
Cancer; 2009 Jun; 117(3):167-73. PubMed ID: 19365828
[TBL] [Abstract][Full Text] [Related]
15. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.
Vergara-Lluri ME; Hu E; Rao JY; Levin M; Apple SK; Moatamed NA
Arch Pathol Lab Med; 2014 Sep; 138(9):1215-22. PubMed ID: 25171704
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-risk urothelial carcinoma: an unresolved problem?
Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
19. Combinations of urine-based tumour markers in bladder cancer surveillance.
Horstmann M; Patschan O; Hennenlotter J; Senger E; Feil G; Stenzl A
Scand J Urol Nephrol; 2009; 43(6):461-6. PubMed ID: 19903092
[TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms].
García Peñalver C; Pérez Barrios A; Leiva Galvis O
Actas Urol Esp; 2005 Jun; 29(6):535-41. PubMed ID: 16092675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]